Related Experiment Video
Updated: Jun 3, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
In outpatients with COVID-19 during Omicron variant circulation, some antivirals reduce time to recovery
Tilemachos Koutouratsas1, Tarek Dammad1, Eleftherios Mylonakis1
1Houston Methodist Hospital, Houston, Texas, USA (T.K., T.D., E.M.).
Clinical Impact Ratings:
GIM/FP/GP: [Formula: see text] Infectious Disease: [Formula: see text] Public Health: [Formula: see text].
More Related Videos
11:43Procedures for the Identification of SARS-CoV-2 Entry Inhibitors as Potential Antivirals using MLV-Based Pseudoviruses
Published on: February 27, 2026
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Related Concept Videos
Antiviral Nucleoside Inhibitors
Inhibitors of Viral Protein Synthesis
Myocarditis III: Medical Management
Retrovirus Life Cycles
Inhibitors Of Virion Release
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...